Abstract:Over the last few decades, stem cell-based therapy has become a novel strategy for a variety of disorders including cardiovascular, digestive and respiratory diseases. Among the stem cells investigated, mesenchymal stem cells (MSCs) are the ideal candidate cell source due to their many characteristics, including ease of isolation and expansion, multilineage differentiation potential and immunoregulatory function. Nevertheless MSCs derived from aged donors or patients with agerelated diseases are senescent (Shi et al., 2021). In addition, prolonged in vitro expansion induces MSC senescence (Li et al., 2019). Although allogeneic transplantation of MSCs exerts beneficial effects in the early days post-transplantation, long-term benefits compared with those of autologous MSCs are compromised due to sustained immunorejection (Huang et al., 2010). Senescence severely affects the characteristics and function of MSCs, limiting their application in regenerative medicine. Exploring effective strategies to rejuvenate autologous senescent MSC and improve their therapeutic capacity is vital. Although multiple factors including age, oxidative stress and mitochondrial dysfunction have been reported to mediate MSC senescence, the underlying mechanisms of this senescence remain unclear. There are twelve manuscripts in this Research Topic, highlighting the current understanding of the potential mechanisms underlying MSC senescence and novel strategies to rejuvenate the senescent MSC. Liu et al. and Zhou et al. summarize the current knowledge of phenotypic and biological properties of senescent MSCs and strategies for monitoring and rejuvenation, including gene modification and pretreatment strategies (Liu et al.; Zhou et al.). They also systematically review the molecular mechanisms underlying MSC senescence including epigenetic changes, autophagy, mitochondrial dysfunction and telomere shortening. There is accumulating evidence that autophagy acts as a positive and negative regulator of MSC senescence (Ma et al., 2018; Yang et al., 2018). Rastaldo et al. discuss these conflicting roles of autophagy in MSC senescence and potential mechanistic explanations for such an intricate liaison (Rastaldo et al.). Sirtuin 3 (SIRT3), an NAD + -dependent deacetylase, regulates a variety of physiological and pathological processes including aging and aging-related diseases. Ma et al. have shown that reduced Sirt3 expression contributes to age-related natural senescence and H2O2-induced premature senescence of rat bone marrow (BM)-MSCs by stimulating cellular reactive oxygen species (ROS) production and DNA injury (Ma et al.). Overexpressing Sirt3 partly reversed the senescence-associated phenotypic features of natural and premature senescent MSCs by alleviating ROS generation and upregulating SOD2 expression. Qin et al. reveal that knockout of NO synthase 2 significantly promoted the adipogenic, but not osteogenic, differentiation capacity of rat MSCs (Qin et al.). Notably, they also showed that knockout of NOS2 in MSCs resulted in significant obesity in rat fed a high-fat diet. Edited by: Atsushi Asakura, University of Minnesota Twin Cities, United States

Proteomic analysis of proteins associated with cellular senescence by calorie restriction in mesenchymal stem cells

Role of SIRT1 and AMPK in mesenchymal stem cells differentiation.

Autophagy inhibits the mesenchymal stem cell aging induced by D-galactose through ROS/JNK/p38 signalling

High Glucose Induces the Aging of Mesenchymal Stem Cells Via Akt/mTOR Signaling

[Effects of Resveratrol on Aging of Mesenchymal Stem Cells and Its Mechanism].

Senescence in Mesenchymal Stem Cells: Functional Alterations, Molecular Mechanisms, and Rejuvenation Strategies.

Coenzyme Q10 Inhibits the Aging of Mesenchymal Stem Cells Induced by D-galactose Through Akt/mTOR Signaling.

GW24-e2135 SIRT1 Significantly Influences Old Sourced MSCs Aging and Proliferation

RNA sequencing profiles reveal dynamic signaling and glucose metabolic features during bone marrow mesenchymal stem cell senescence

Regulatory Effects of Senescent Mesenchymal Stem Cells: Endotheliocyte Reaction

Comparison of Senescence-Related Changes Between Three- and Two-Dimensional Cultured Adipose-Derived Mesenchymal Stem Cells

Editorial: Mesenchymal Stem Cell Senescence and Rejuvenation

An unbiased proteomics approach to identify the senescence-associated secretory phenotype of human bone marrow-derived mesenchymal stem cells

[Changes of biological characteristics and gene expression profile of umbilical cord mesenchymal stem cells during senescence in culture]

Effect of age on growth and senescence of human bone mesenchymal stem cells

Decreased Mir-17-92 Cluster Correlates with Senescence Features, Disrupted Oxidative Homeostasis, and Impaired Therapeutic Efficacy of Mesenchymal Stem Cells

Transcriptome and lipidome profile of human mesenchymal stem cells with reduced senescence and increased trilineage differentiation ability upon drug treatment

MicroRNA profiling reveals age-dependent differential expression of nuclear factor κB and mitogen-activated protein kinase in adipose and bone marrow-derived human mesenchymal stem cells

Effect of aging on the pluripotential capacity of human CD105+ mesenchymal stem cells

Aging alters tissue resident mesenchymal stem cell properties

Dysfunction of metabolic activity of bone marrow mesenchymal stem cells in aged mice